SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
New Chief for Canada's Cancer Research Society
December 15, 2016
Cancer Immunotherapies Space "to Witness Extraordinary Growth"
December 13, 2016
Pharma R&D Returns Continue to Fall
Exponential Medicine and Pharma's Unfulfilled Promise
Bill Drummy reviews the "techno-optimistic" highlights of this year's Exponential Medicine conference in San Diego.
EFPIA Appoints Interim Director General
December 12, 2016
First Generic Equivalent to Tamiflu Capsules Launched in US
The State of Market Insights in Pharma
It's time to take advantage of a nascent technology embrace taking hold among market insights professionals, writes Janet Kolsoff.
Global Spending on Medicine Predicted to Reach $1.5 Trillion by 2021
December 08, 2016
New CEO for Muse bio
Astellas Championed for LGBT Equality in the Workplace
December 06, 2016
Taro Appoints Interim CEO
December 05, 2016
Pamela Fralick to Head Canadian Pharma Association
Pfizer and Watson Health Announce Immuno-oncology Collaboration
December 01, 2016
Smaller Companies to Gain Traction in Seasonal Influenza Vaccine Market
01 December, 2016.
Improving Customer Data a "Top Priority" for European Pharma
November 30, 2016.
Pharma Must Embrace Digital Transformation
However conservative and heavily regulated the drugs business, it too must transform itself to exploit digital opportunities - if only to ward off disruption, says Elvis Paćelat.
Medical Tourism Will Drive Thailand’s Pharma Market to $9.5 Billion by 2020
November 29, 2016
Allergan Acquires Chase Pharmaceuticals
November 23, 2016
Healthcare Companies "Must Embrace New Funding Sources"
UK Pathology Services "at Tipping Point"
UK Prime Minister Announces Post-Brexit Boost for Science R&D
November 21, 2016
Digital Spending by Life Sciences Marketers to Grow to $14.25 BN by 2018
Pfizer Expands Humanitarian Assistance Program
November 20, 2016
Digital Disruption is Coming: Are You Ready?
The steps to stay ahead of the looming shakeup in pharma.
Cancer Market "Will Soar to $7.5 Billion by 2022"
November 17, 2016
Nonadherence Cost Pharma an Estimated $637 Billion in 2015, Says Report
November 16, 2016
Roche Launches Immunotherapy Research Network
Broad Institute and IBM Begin Cancer Drug Resistance Research
November 11, 2016
Absence of Drugs Targeting Negative Symptoms to Slow Schizophrenia Treatment Market Growth
November 09, 2016
Newly Discovered Protein May Hold Key to Better Drugs for Neglected Diseases
November 07, 2016